Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Pfizer 1Q

U.S. revenues were $5.0 billion (-10%) and International revenues were $5.9 billion (-7%). Foreign exchange unfavorably impacted revenues by approximately 5%.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer 1Q

1Q Revenues: $10.9 billion (-8%)

1Q Earnings: $2.7 billion (-2%)

Comments: U.S. revenues were $5.0 billion (-10%) and International revenues were $5.9 billion (-7%). Foreign exchange unfavorably impacted revenues by approximately 5%. Results were impacted by loss of U.S. exclusivity for Zyrtec in January 2008 and Camptosar in February 2008, revenue declines for Lipitor and Chantix, as well as costs incurred in connection with the pending Wyeth acquisition. Oncology revenues were $350 million (-17%). Lipitor sales were down 13% to $2.7 billion and Chantix sales were down 36% to $177 million, impacted by revised labeling warnings. Lyrica sales were $684 million (+17%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters